We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Nobel Prize Awarded for Fundamental Discoveries in the Developmental Capacity of Mature Cells

By LabMedica International staff writers
Posted on 15 Oct 2012
The 2012 Nobel Prize for Physiology or Medicine jointly awarded to scientists John B. More...
Gurdon and Shinya Yamanaka recognizes the fundamental nature of their discoveries about the capacity of mature, specialized cells to be reprogrammed back into immature, pluripotent stem-like cells. The prize also reflects recognition of important progress being made in medical research based on these groundbreaking discoveries.

The process of developing from an immature into a specialized cell was previously considered to be unidirectional and irreversible. It was thought that during maturation the cell undergoes certain changes that include loss of the capacity to return to a pluripotent stage. John B. Gurdon, long-time professor of cell biology at the University of Cambridge (Cambridge, UK) and currently at the Gurdon Institute (Cambridge, UK), challenged this dogma that the specialized cell is irreversibly committed. In 1962, Prof. Gurdon published a landmark study in the Journal of Embryology and Experimental Morphology titled “The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles.” In this classic experiment, he replaced the immature nucleus of a frog egg cell with the nucleus from a mature intestinal cell. This modified egg cell developed into a normal tadpole, showing that the DNA of the mature cell still contained all the genetic information required for the development of all the cells of a fully functional frog. This conclusion was eventually confirmed and generalized to other organisms, including mammals, by independent studies performed by other researchers.

Prof. Gurdon’s experiment involved mechanical removal of intact nuclei from cells and introduction of a nucleus from a specialized cell into a de-nucleated nonspecialized cell. Over 40 years later, Shinya Yamanaka, currently professor at Kyoto University (Kyoto, Japan) and affiliated with the Gladstone Institutes (San Francisco, CA, USA), discovered that it was also possible to reprogram fully intact mature cells to become pluripotent cells by the introduction of only a few specific genes in a specific combination, discovered by testing various combinations from a set of previously identified candidate genes. This groundbreaking study from Prof. Yamanaka’s laboratory was published in 2006 in the journal Cell, titled “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.” These induced pluripotent stem cells (iPSC) have already constituted another breakthrough in developmental biology. And by reprogramming also human cells, scientists have created new opportunities to study human disease mechanisms and develop methods for medical therapy and diagnosis.

Related Links:

Nobel Foundation
Gurdon Institute
Kyoto University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Automated Clinical Chemistry Analyzer
Envoy 500+
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.